By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
A home oxygen concentrator is a type of oxygen delivery system that pulls in ambient air, eliminates nitrogen and other gases, and then distributes purified oxygen to the user. Home oxygen concentrators produce oxygen constantly (at a constant rate) and must be hooked into an electrical outlet to function.
High-flow nasal cannula (HFNC) therapy is a type of oxygen delivery system that can deliver up to 100% humidified and heated oxygen at a flow rate of up to 60 litres per minute.
In comparison to cold and dry oxygen, HFNO increases the fraction of inspired oxygen, lowers dead space, cleanses it, produces positive end-expiratory pressure (PEEP), and offers more comfort.For usage at home, high-flow therapy systems have been developed.
For those with higher oxygen needs, continuous flow portable oxygen concentrators for home oxygen concentrators may be the best option. Machines that produce oxygen continuously instead of pulse-wise can deliver more oxygen.
The Global high flow oxygen therapy devices market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
Nocca Robotics launches High-Flow Oxygen Therapy Device Noccarc H210 for critical care treatment of COVID-19 patients.Nocca Robotics Pvt Ltd, an incubator firm of SIIC, IIT Kanpur, which offers scientifically validated, accredited, and high-quality critical care equipment, has introduced a High-Flow Oxygen Therapy Device in an effort to aid COVID-19 patients.
The state-of-the-art tool is simple to use and pleasant for the patients, and it has been shown to be successful in the treatment of COVID-19 patients. The likelihood of intubation is dramatically decreased by high-flow oxygen therapy.
The present pandemic and the increasing number of COVID-19 patients address the urgent need for high flow oxygen treatment devices in the nation, which is addressed by the Noccarc H210.
Through a nasal cannula, the HFOT (High-Flow Oxygen Therapy Device) delivers humidified, oxygen-rich air to patients, boosting the amount of oxygen delivered to the blood. Oral suctioning and expectoration are made simple by high-flow oxygen therapy.
The enhanced epithelial muco-ciliary caused by the heated and humidified gas also reduces the incidence of respiratory problems including pneumonia and delirium. The patient’s ability to speak with the medical staff is facilitated by the use of a cannula in HFOT, which also lowers the patient’s chance of developing tomophobia as a result of intubation.
Noccarc H210 produces humidified air at a regulated set temperature and humidity levels using a servo humidifier. The Noccarc H210 is equipped with cutting-edge technology, including a turbine-based flow generator, electronic FiO2 control with inputs for high- and low-pressure oxygen, and a 4.3-inch touch screen interface for simple accessibility.
Additionally, the device has two temperature sensors and an inbuilt heater. Healthcare practitioners may utilise the adaptable solution on both adults and children with changeable flow rate thanks to its adult and paediatric modes.
The Noccarc H210 was thoughtfully designed for comfort and usage and has a number of alarms to notify medical personnel in case of tube blockage or disconnect, unplugged temperature sensor, disconnected heater wire, or even in the situation of extremely high or extremely low oxygen supply to the patient.
